Biotech China 2014

Drug Design: Schering Plough

Total Score People Score Events Score
22 18 20
Date Event Presentation Speakers
November 2, 2009 Track 4: Fourth Annual GPCR-based drug discovery Case Study of Preladenant, an A2A Antagonist for the Treatment of Parkinson’s Disease Andy Stamford
November 2, 2009 Track 3: Fourth Annual Ion Channels as Therapeutic Targets Ion Channels in Metabolic Diseases Chuan-Chu Chou
July 1, 2009 Advances in Oral Dose Manufacturing Assessing the Issues in Blend Uniformity – Moving From Art to Science Kaspar van den Dries
June 4, 2009 Structure-Based Drug Design Discovery of Novel Cyclin-Dependent Kinases Inhibitors: A CDK2 Case Study in Structure-Based Drug Design José Duca
Thinking Out Loud, a Day One Closing Panel: Are we ready for a GPCR structural explosion? José Duca
Chairperson’s Remarks José Duca
April 7, 2009 Inaugural HIV Inhibitors Topic 14: Increasing the Barrier to Drug Resistance by Targeting Viral Cellular Interactions John Howe
Screening for Inhibitors of HIV Integrase - LEDGF/p75 Interaction John Howe
December 9, 2008 3rd Annual Congress Strategies to enhance Solubility and Drug Absorption Screening for polymorphs and the impact on drug solubility Paulo Leanardo Garcia,
November 20, 2008 5TH LATIN AMERICAN CONGRESS OF CLINICAL RESEARCH REGIONAL PERSPECTIVES AND FUTURE TRENDS A) Biomarkers and surrogate endpoints in Clinical Trials. Towards translational medicine. Erik Sprengers
D Latin America experience with EDC and use of electronic diaries in clinical trials. Luis E. Ramirez-Arizmendi
E) Signal enhacement in psychiatric patients Joep , . Schoemaker
November 13, 2008 4th National Rx Drug Pricing Boot Camp Case Study: Understanding the Interrelationship of Pricing Methodologies and How One Price May Affect Another David Ralston
November 12, 2008 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Setting the Stage for Success by Choosing the Right Partner and Conducting Effective Due Diligence Paul Thompson
October 21, 2008 Ion Channels as therapeutic targets Chairperson’s Remarks Chuan-Chu Chou
Correlating in vitro Potency with in vivo Efficacy for Ion Channel Modulators, Primary Cell Lines and Automated Patch Clamp Systems for Screening, Outside the Box: Are There Non-Conventional Ways for Ion Channel-Based Drug Discovery? Chuan-Chu Chou
Chairperson’s Remarks Chuan-Chu Chou
October 14, 2008 Crystal Form Selection and Crystallisation of API Scale-up during polymorph selection with simple tools to translate into later-stage development Mike Song
September 9, 2008 Ion Channel Targets Ion Channel-Based Drug Discovery: Opportunities and Challenges Chuan-Chu Chou
March 25, 2008 CYTOKINE-BASED THERAPEUTICS Sch527123-a Potent CXCR2 Antagonist R. William Hipkin
December 3, 2007 PharmSep FOCUS GROUP 2 Modern Methods and Instrumentation for LC-MS Jim X. Shen
F: High Temperature: A New Frontier in Highly Efficient and Selective Bioanalysis of New Chemical Jim X. Shen
INTERACTIVE FOCUS GROUPS: FOCUS GROUP 3 Advanced Chromatography- Fast Separations Jim X. Shen
December 3, 2007 Pharma Sep FOCUS GROUP 2 Modern Methods and Instrumentation for LC-MS Jim X. Shen
F: High Temperature: A New Frontier in Highly Efficient and Selective Bioanalysis of New Chemical Jim X. Shen
INTERACTIVE FOCUS GROUPS: FOCUS GROUP 3 Advanced Chromatography- Fast Separations Jim X. Shen
December 1, 2007 47TH American Socieity of Cell Biology BD Biosciences:The Importance of Surface Modifi cations/Coatings for Improving Cell Culture Kevin Chen
November 27, 2007 Fifth Annual Strategic Resource Management: The Key to Increasing R&D Productivity Nov (27-28) PRE-CONFERENCE WORKSHOP Part 2: Laboratory Asset Management -Maximizing Your Investment in Laboratory Equipment (10:30-11:30) Walter Faraci
PRE-CONFERENCE WORKSHOP Part 1: Laboratory Asset Management -Maximizing Your Investment in Laboratory Equipment (08:30-10:00) Walter Faraci
PRE-CONFERENCE WORKSHOP: Laboratory Asset Management -Maximizing Your Investment in Laboratory Equipment (08:30-11:30) Walter Faraci
November 7, 2007 Bridging the Business Development/Alliance Management Interface Nov(7-8) The Bus Dev/Alliance Management Interface ... Making a Difference During Negotiations to Enhance the Value of Partnerships (13:35-14:20) Ratnakar Mitra
Bridging the Business Development/Alliance Management GAP and Beyond: GOVERNANCE AND PERFORMANCE - A Panel Discussion (11:50-12:50) Ratnakar Mitra
November 5, 2007 Bio-Pharma Alliance Summit Nov (05-06) Biotech and Pharma Perspectives on Operating Guidelines for the Effective Management of Alliances (14:10-14:50) Xavier Avat
Panel Discussion: Pharma and Biotech Perspectives on Operating Guidelines for Effective Management of Co-Development Alliances An ASAP- CHI (15:30-16:10) Xavier Avat
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) POTASSIUM CHANNELS AND DISEASE (14:10-15:45) Chuan-Chu Chou
POTASSIUM CHANNELS AND DISEASE: An Emerging Target for Several Major Diseases of Unmet Medical Needs (14:15-14:45) Chuan-Chu Chou
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.